Is sickle cell disease an autosomal recessive, autosomal dominant, X-linked recessive, or X-linked dominant disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sickle Cell Disease is an Autosomal Recessive Disorder

Sickle cell disease (SCD) is definitively an autosomal recessive genetic disorder characterized by the presence of sickle hemoglobin (HbS) in red blood cells. 1

Genetic Basis of Sickle Cell Disease

  • SCD results from a single DNA base-pair change in the beta-globin gene that leads to the expression of sickle hemoglobin (HbS)
  • The mutation causes a single amino acid substitution (glutamic acid to valine) in the beta-globin chain 1
  • For a person to have SCD, they must inherit two abnormal hemoglobin genes - one from each parent 1
  • When both parents carry the trait (heterozygotes), there is a 25% chance with each pregnancy that their child will have SCD

Inheritance Pattern Confirmation

Multiple high-quality guidelines explicitly state that SCD follows an autosomal recessive inheritance pattern:

  • The American Academy of Pediatrics states: "SCD is an autosomal recessive genetic disorder characterized by the presence of sickle hemoglobin (HbS) in red blood cells" 1
  • The American Journal of Hematology confirms: "SCD is an autosomal recessively inherited β-hemoglobinopathy associated with significant morbidity and mortality" 1
  • The American Heart Association/American Stroke Association guidelines also identify SCD as "an autosomal recessive inherited hemoglobinopathy" 1

Clinical Implications of the Autosomal Recessive Pattern

The autosomal recessive inheritance pattern has important implications for:

  1. Genetic Counseling: Documentation of parental testing is essential when counseling families about genetic risk 1

    • Solubility testing (SickleDex) is not adequate for carrier testing
    • Complete blood count and hemoglobinopathy testing are required
  2. Carrier Status: Individuals with sickle cell trait (one abnormal gene) are generally asymptomatic carriers but can pass the gene to their children

  3. Disease Expression: The disease only manifests when a person inherits two copies of the abnormal gene (homozygous state) 1

Common Genotypes of Sickle Cell Disease

Several genotypes result from inheriting different combinations of abnormal hemoglobin genes:

  • HbSS (homozygous sickle cell disease) - most common and severe form
  • HbSC (sickle hemoglobin C disease)
  • HbS/β⁰-thalassemia (no normal beta-globin production)
  • HbS/β⁺-thalassemia (reduced normal beta-globin production) 1

Distinguishing from Other Inheritance Patterns

SCD is definitively not:

  • Autosomal dominant (would require only one copy of the abnormal gene to cause disease)
  • X-linked recessive (would affect males predominantly and be transmitted through female carriers)
  • X-linked dominant (would affect both males and females but be transmitted through the X chromosome)

Clinical Relevance

Understanding the autosomal recessive inheritance pattern is crucial for:

  • Accurate genetic counseling for families
  • Appropriate screening of family members
  • Prenatal diagnosis options
  • Population screening programs in high-risk communities

The autosomal recessive nature of SCD explains why it is more prevalent in certain populations where the carrier state confers protection against malaria, leading to evolutionary selection of the trait in these regions 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.